Coloplast A/S (COLO-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.162x

Based on the latest financial reports, Coloplast A/S (COLO-B) has a cash flow conversion efficiency ratio of 0.162x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr2.23 Billion ≈ $349.37 Million USD) by net assets (Dkr13.80 Billion ≈ $2.16 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See COLO-B defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Coloplast A/S - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Coloplast A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Coloplast A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Coloplast A/S ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Skyverse Technology Co. Ltd. A
SHG:688361
N/A
Julius Baer Gruppe AG
SW:BAER
0.767x
ENKA Insaat ve Sanayi AS
IS:ENKAI
0.022x
Investment AB Latour (publ)
ST:LATO-B
0.021x
CNA Financial Corporation
NYSE:CNA
0.064x
Korea Zinc Inc
KO:010130
-0.010x
HDFC Asset Management Company Limited
NSE:HDFCAMC
0.130x
UPM-Kymmene Oyj
HE:UPM
0.017x

Annual Cash Flow Conversion Efficiency for Coloplast A/S (2002–2025)

The table below shows the annual cash flow conversion efficiency of Coloplast A/S from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see COLO-B company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 Dkr16.12 Billion
≈ $2.52 Billion
Dkr6.64 Billion
≈ $1.04 Billion
0.412x +167.36%
2024-09-30 Dkr17.94 Billion
≈ $2.81 Billion
Dkr2.77 Billion
≈ $432.76 Million
0.154x -36.89%
2023-09-30 Dkr17.30 Billion
≈ $2.71 Billion
Dkr4.23 Billion
≈ $661.19 Million
0.244x -60.27%
2022-09-30 Dkr8.29 Billion
≈ $1.30 Billion
Dkr5.10 Billion
≈ $797.78 Million
0.615x -5.05%
2021-09-30 Dkr8.17 Billion
≈ $1.28 Billion
Dkr5.29 Billion
≈ $827.66 Million
0.648x +0.79%
2020-09-30 Dkr7.41 Billion
≈ $1.16 Billion
Dkr4.76 Billion
≈ $744.58 Million
0.643x +1.96%
2019-09-30 Dkr6.91 Billion
≈ $1.08 Billion
Dkr4.36 Billion
≈ $681.68 Million
0.630x -7.25%
2018-09-30 Dkr6.42 Billion
≈ $1.00 Billion
Dkr4.36 Billion
≈ $682.31 Million
0.679x +24.40%
2017-09-30 Dkr5.95 Billion
≈ $931.23 Million
Dkr3.25 Billion
≈ $508.64 Million
0.546x -8.58%
2016-09-30 Dkr5.07 Billion
≈ $792.93 Million
Dkr3.03 Billion
≈ $473.75 Million
0.597x -15.74%
2015-09-30 Dkr4.71 Billion
≈ $736.29 Million
Dkr3.34 Billion
≈ $522.10 Million
0.709x +41.48%
2014-09-30 Dkr6.28 Billion
≈ $983.02 Million
Dkr3.15 Billion
≈ $492.68 Million
0.501x +8.18%
2013-09-30 Dkr6.77 Billion
≈ $1.06 Billion
Dkr3.14 Billion
≈ $490.65 Million
0.463x +5.67%
2012-09-30 Dkr6.04 Billion
≈ $945.31 Million
Dkr2.65 Billion
≈ $414.46 Million
0.438x -10.96%
2011-09-30 Dkr4.48 Billion
≈ $700.62 Million
Dkr2.21 Billion
≈ $344.99 Million
0.492x -3.91%
2010-09-30 Dkr3.45 Billion
≈ $540.09 Million
Dkr1.77 Billion
≈ $276.77 Million
0.512x -20.19%
2009-09-30 Dkr2.85 Billion
≈ $445.90 Million
Dkr1.83 Billion
≈ $286.32 Million
0.642x +11.11%
2008-09-30 Dkr2.29 Billion
≈ $358.44 Million
Dkr1.32 Billion
≈ $207.15 Million
0.578x +38.15%
2007-09-30 Dkr2.40 Billion
≈ $375.50 Million
Dkr1.00 Billion
≈ $157.08 Million
0.418x +21.47%
2006-09-30 Dkr2.81 Billion
≈ $438.86 Million
Dkr966.00 Million
≈ $151.14 Million
0.344x -36.01%
2005-09-30 Dkr2.51 Billion
≈ $393.33 Million
Dkr1.35 Billion
≈ $211.69 Million
0.538x +51.45%
2004-09-30 Dkr2.37 Billion
≈ $370.25 Million
Dkr840.90 Million
≈ $131.57 Million
0.355x -21.60%
2003-09-30 Dkr2.01 Billion
≈ $314.48 Million
Dkr911.00 Million
≈ $142.53 Million
0.453x -22.11%
2002-09-30 Dkr1.57 Billion
≈ $245.48 Million
Dkr913.00 Million
≈ $142.85 Million
0.582x --

About Coloplast A/S

CO:COLO-B Denmark Medical Instruments & Supplies
Market Cap
$12.33 Billion
Dkr78.80 Billion DKK
Market Cap Rank
#1927 Global
#12 in Denmark
Share Price
Dkr380.00
Change (1 day)
+0.05%
52-Week Range
Dkr376.30 - Dkr630.60
All Time High
Dkr1106.54
About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more